EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Topiramate prophylaxis and response to triptan treatment for acute migraine



Topiramate prophylaxis and response to triptan treatment for acute migraine



Headache 46(9): 1424-1430



Objective.-To evaluate the effect of topiramate migraine prophylaxis on subject responsiveness to triptans used for acute symptomatic migraine treatment.Background.-Clinical experience suggests that prophylactic migraine treatment may enhance the efficacy of symptomatic medications used to treat acute migraine attacks.Methods.-This open-label, single-arm multicenter study consisted of a 6-week baseline period followed by a 16-week topiramate treatment period. Subjects meeting International Headache Society (IHS) criteria for migraine with and without aura signed consent and entered the baseline period. Those with 3 to 12 migraine periods per month during baseline received topiramate prophylactic treatment. Only patients who completed at least 12 weeks of topiramate treatment were included in the data analysis.Results.-Of 55 patients screened, 40 subjects entered the topiramate treatment period and 21 subjects received at least 12 weeks of treatment. Mean final dose of topiramate was 124 mg per day (range 50 to 200 mg per day). During the baseline period, the mean percentage of attacks rendered pain-free at 2 hours for the 21 subjects was 46.9% (SD = 31.9), while during the topiramate treatment period it was 44.6% (SD = 32.2) (P = .8). On topiramate, after the first 8 weeks of dosage titration, patients experienced a mean of 3.68 migraine attacks/month, compared to 4.31 during the baseline period (P < .03). Thirteen subjects discontinued because of adverse events. The most commonly reported adverse events were paresthesia, fatigue, anxiety, and dizziness.Conclusion.-Although topiramate prophylaxis did reduce migraine attack frequency, in this pilot study topiramate prophylactic migraine treatment did not increase the proportion of patients pain-free 2 hours after symptomatic triptan therapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 012698331

Download citation: RISBibTeXText

PMID: 17040339

DOI: 10.1111/j.1526-4610.2006.00531.x



Related references

Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis. Headache 52(1): 57-67, 2012

Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). Clinical Therapeutics 26(9): 1533-1545, 2004

Do we need another triptan for the acute treatment of migraine headache?. EOS-Rivista di Immunologia ed Immunofarmacologia 18(3-4): 99-104, 1998

Post-triptan era for the treatment of acute migraine. Current Pain and Headache Reports 8(5): 393-398, 2004

Topiramate as an adjunctive treatment in migraine prophylaxis. Headache 43(10): 1080-1084, 2003

Costs and utilization of triptan users who receive drug prophylaxis for migraine versus triptan users who do not receive drug prophylaxis. Journal of Managed Care Pharmacy 11(2): 137-144, 2005

New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Lancet 376(9741): 645-655, 2010

Acute myopia and angle closure caused by topiramate, a drug used for prophylaxis of migraine. Indian Journal of Ophthalmology 54(3): 195-197, 2006

Topiramate-induced depression in cases using topiramate for migraine prophylaxis. Cephalalgia 30(6): 747-749, 2011

Migraine prophylaxis with topiramate Results of double-blind, placebo-controlled, dose-response trials. Epilepsia 44(Supplement 9): 106-107, 2003

Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42(8): 796-803, September, 2002

Low-dose topiramate in migraine and transformed migraine prophylaxis. Cephalalgia 23(7): 721, September, 2003

A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis. Pain Medicine 13(1): 80-86, 2012

Courtship and mating behaviour of manta rays Mobula alfredi and M. birostris in the Maldives. Journal of Fish Biology, 2018

Topiramate in migraine prophylaxis. Neurological Sciences 26 Suppl 2: S130-S133, 2005